Cargando…
Immunity in Hodgkin's disease: status after 5 years' remission.
Immunological indices have been reassessed in 27 patients in remission from Hodgkin's disease for 5 years after treatment and the findings correlated with initial treatment and splenectomy status. Neutrophil counts were lower and lymphocyte and monocyte counts higher at 5 years' remission...
Autores principales: | Hancock, B. W., Bruce, L., Whitham, M. D., Dunsmore, I. R., Ward, A. M., Richmond, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011201/ https://www.ncbi.nlm.nih.gov/pubmed/7138765 |
Ejemplares similares
-
Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission.
por: Hancock, B. W., et al.
Publicado: (1977) -
Immunity in Hodgkin's disease: status after 10 years remission.
por: Bruce, L. J., et al.
Publicado: (1990) -
Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission
por: Nagashima, Kana, et al.
Publicado: (2020) -
Dysfunctional endothelial progenitor cells in patients with Hodgkin’s lymphoma in complete remission
por: Wiessman, Maya, et al.
Publicado: (2018) -
A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2023)